Current and historical daily PE Ratio for HUTCHMED (China) Ltd (
HKSE:00013
) from 2021 to May 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. HUTCHMED (China) stock (HKSE:00013) PE ratio as of May 06 2024 is 36.96.
More Details
HUTCHMED (China) Ltd (HKSE:00013) PE Ratio (TTM) Chart
HUTCHMED (China) Ltd (HKSE:00013) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 702
- 1
- 2
- 3
- 4
- 5
- 6
- 8
| HUTCHMED (China) PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-06 | 37.0 | 2024-02-27 | 28.7 |
| 2024-05-03 | 35.6 | 2024-02-26 | 27.9 |
| 2024-05-02 | 35.8 | 2024-02-23 | 28.7 |
| 2024-04-30 | 35.0 | 2024-02-22 | 27.8 |
| 2024-04-29 | 35.9 | 2024-02-21 | 26.8 |
| 2024-04-26 | 35.2 | 2024-02-20 | 26.7 |
| 2024-04-25 | 35.2 | 2024-02-19 | 26.0 |
| 2024-04-24 | 34.0 | 2024-02-16 | 26.3 |
| 2024-04-23 | 32.9 | 2024-02-15 | 24.6 |
| 2024-04-22 | 31.2 | 2024-02-14 | 24.0 |
| 2024-04-19 | 30.1 | 2024-02-09 | 25.4 |
| 2024-04-18 | 30.2 | 2024-02-08 | 25.3 |
| 2024-04-17 | 30.8 | 2024-02-07 | 25.3 |
| 2024-04-16 | 30.9 | 2024-02-06 | 24.6 |
| 2024-04-15 | 32.7 | 2024-02-05 | 22.2 |
| 2024-04-12 | 33.5 | 2024-02-02 | 22.7 |
| 2024-04-11 | 33.4 | 2024-02-01 | 23.2 |
| 2024-04-10 | 33.0 | 2024-01-31 | 22.9 |
| 2024-04-09 | 33.5 | 2024-01-30 | 23.2 |
| 2024-04-08 | 31.1 | 2024-01-29 | 23.4 |
| 2024-04-05 | 30.3 | 2024-01-26 | 23.9 |
| 2024-04-03 | 31.6 | 2024-01-25 | 24.9 |
| 2024-04-02 | 31.1 | 2024-01-24 | 24.8 |
| 2024-03-28 | 31.0 | 2024-01-23 | 24.6 |
| 2024-03-27 | 30.9 | 2024-01-22 | 24.1 |
| 2024-03-26 | 30.8 | 2024-01-19 | 26.1 |
| 2024-03-25 | 31.1 | 2024-01-18 | 27.6 |
| 2024-03-22 | 30.3 | 2024-01-17 | 27.8 |
| 2024-03-21 | 31.8 | 2024-01-16 | 29.7 |
| 2024-03-20 | 31.9 | 2024-01-15 | 29.6 |
| 2024-03-19 | 31.8 | 2024-01-12 | 29.7 |
| 2024-03-18 | 32.4 | 2024-01-11 | 30.6 |
| 2024-03-15 | 32.6 | 2024-01-10 | 29.3 |
| 2024-03-14 | 31.7 | 2024-01-09 | 29.4 |
| 2024-03-13 | 32.9 | 2024-01-08 | 29.0 |
| 2024-03-12 | 29.4 | 2024-01-05 | 30.8 |
| 2024-03-11 | 27.5 | 2024-01-04 | 31.8 |
| 2024-03-08 | 27.4 | 2024-01-03 | 31.8 |
| 2024-03-07 | 26.9 | 2024-01-02 | 32.5 |
| 2024-03-06 | 27.4 | 2023-12-29 | 33.3 |
| 2024-03-05 | 25.9 | 2023-12-28 | 32.6 |
| 2024-03-04 | 28.2 | 2023-12-27 | At Loss |
| 2024-03-01 | 27.9 | 2023-12-22 | At Loss |
| 2024-02-29 | 28.0 | 2023-12-21 | At Loss |
| 2024-02-28 | 27.5 | 2023-12-20 | At Loss |
HUTCHMED (China) Ltd (HKSE:00013) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
HUTCHMED (China) Ltd
ISIN : KYG4672N1198
Description
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers